Pediatric Heterotopic Gastric Mucosa of the Cervical Esophagus (Inlet Patch): Case Series with Clinical, Endoscopic, and Histopathological Correlation
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction: Inlet Patch (IP) is a congenital anomaly characterized by gastric heterotopia in the cervical esophagus. While extensively described in adults, it remains poorly characterized in pediatric populations.Material and Methods: This retrospective, single-center study included all pediatric patients (0–14 years) diagnosed with IP between 2018 and 2025. Sociodemographic and clinical data were collected. A blinded pathologist assessed the presence and severity of gastritis within the IP.Results: Nine patients (median age: 12 years) were included, 78% male. Cervical esophageal symptoms were identified in 67%, primarily dysphagia and gastroesophageal reflux disease-related complaints, although concomitant conditions such as eosinophilic esophagitis were frequently present. Endoscopic examination revealed characteristic well-demarcated salmon-red plaques in all patients, with multiple lesions observed in three cases. Histology confirmed gastric heterotopia with varying degrees of chronic inflammation in all cases. A strong correlation was observed between the severity of gastritis in the stomach, the severity of inflammation in the IP, and the presence of H. pylori, with 75% of patients with moderate-to-severe IP inflammation also exhibiting gastric H. pylori-associated gastritis. All patients except one received proton pump inhibitors, and symptoms improved in all cases.Conclusions: A thorough and targeted examination of the cervical esophagus significantly increased IP detection at our center, with most cases (88%) being diagnosed in the last 12 months. While mostly asymptomatic and incidental, IP can be symptomatic. In this case series, we found a correlation between the severity of inflammation in the IP, the severity of gastritis and the presence of H. pylori. Further studies are needed to define pediatric IP clinical significance and optimal management.